In vitro degradability, bioactivity and primary cell responses to bone cements containing mesoporous magnesium–calcium silicate and calcium sulfate for bone regeneration
Open Access
- 6 October 2015
- journal article
- Published by The Royal Society in Journal of The Royal Society Interface
- Vol. 12 (111) , 20150779
Abstract
Mesoporous calcium sulfate-based bone cements (m-CSBC) were prepared by introducing mesoporous magnesium–calcium silicate (m-MCS) with specific surface area (410.9 m² g −1 ) and pore volume (0.8 cm³ g −1 ) into calcium sulfate hemihydrate (CSH). The setting time of the m-CSBC was longer with the increase of m-MCS content while compressive strength decreased. The degradation ratio of m-CSBC increased from 48.6 w% to 63.5 w% with an increase of m-MCS content after soaking in Tris–HCl solution for 84 days. Moreover, the m-CSBC containing m-MCS showed the ability to neutralize the acidic degradation products of calcium sulfate and prevent the pH from dropping. The apatite could be induced on m-CSBC surfaces after soaking in SBF for 7 days, indicating good bioactivity. The effects of the m-CSBC on vitamin D 3 sustained release behaviours were investigated. It was found that the cumulative release ratio of vitamin D 3 from the m-CSBC significantly increased with the increase of m-MCS content after soaking in PBS (pH = 7.4) for 25 days. The m-CSBC markedly improved the cell-positive responses, including the attachment, proliferation and differentiation of MC3T3-E1 cells, suggesting good cytocompatibility. Briefly, m-CSBC with good bioactivity, degradability and cytocompatibility might be an excellent biocement for bone regeneration.Keywords
This publication has 38 references indexed in Scilit:
- Preparation, bioactivity, degradability and primary cell responses to an ordered mesoporous magnesium–calcium silicateMicroporous and Mesoporous Materials, 2012
- Influence of strontium for calcium substitution in bioactive glasses on degradation, ion release and apatite formationJournal of The Royal Society Interface, 2011
- Biocompatibility of magnesium phosphate minerals and their stability under physiological conditionsActa Biomaterialia, 2011
- Vitamin D deficiency promotes growth of MCF-7 human breast cancer in a rodent model of osteosclerotic bone metastasisBone, 2010
- The three-stage in vitro degradation behavior of mesoporous silica in simulated body fluidMicroporous and Mesoporous Materials, 2010
- Customized Ca–P/PHBV nanocomposite scaffolds for bone tissue engineering: design, fabrication, surface modification and sustained release of growth factorJournal of The Royal Society Interface, 2010
- Development of magnesium calcium phosphate biocement for bone regenerationJournal of The Royal Society Interface, 2010
- Bone tissue engineering therapeutics: controlled drug delivery in three-dimensional scaffoldsJournal of The Royal Society Interface, 2009
- Bioactive ceramic-based materials with designed reactivity for bone tissue regenerationJournal of The Royal Society Interface, 2009
- The biocompatibility of mesoporous silicatesBiomaterials, 2008